Seth Hanson

Gilson (United States)

Papers

2

Total Citations

28

H-Index

2

About

Seth Hanson has established himself as a key innovator in the field of pluripotent stem cell bioprocessing, with a focused expertise in scalable manufacturing and automation. His major contribution lies in pioneering the use of robotic liquid handling systems for the standardized culture and production of induced pluripotent stem cells (iPSCs). Specifically, his landmark 2015 work on a scalable 96-well plate platform directly addresses a critical bottleneck in regenerative medicine: transitioning from small-scale, manual laboratory protocols to high-throughput, cost-effective production. This work, which has garnered over 28 citations, provides a practical framework for producing stem cell-derived biopharmaceuticals and cells for tissue engineering. By demonstrating a robust, automated method for iPSC expansion, Hanson’s research is instrumental in closing the gap between fundamental stem cell biology and clinical application, enabling more reproducible and efficient workflows for drug discovery and safety testing. His achievements highlight a vital pathway toward making cell-based therapies a commercial and clinical reality.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
22 citations · 2015
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Gilson (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago